北京弘润天源生物技术 Cellonis Biotechnologies
京弘润天源生物技术有限公司是一家专业从事细胞治疗研究与临床应用的生物技术公司,公司秉承为细胞治疗进行最好推广、最佳服务的宗旨,以“细胞治疗的供应和临床服务”为运营理念,以搭建生产中心为核心的生产网络是运营模式,以技术支持、细胞供应、临床研究和咨询为服务方式,实现产业化发展。公司拥有通过SFDA认证的GMP生产车间并配置先进的细胞生产设备,拥有系统的细胞生产管理规范与管理制度,为细胞的临床应用提供了有效的保障。
Cellonis Biotechnologies Group is a China based biotechnology company focus primarily on the development and applying of novel stem cell technologies for providing the effective, patient-specific therapies to patients with degenerative central nervous system (CNS) disorders, cardiovascular diseases, liver diseases and cancers.
Based on the over 5 years experience of extensive research and treatment protocol development, we have built up an advance stem cell platform technology and more than 5 stem cell therapy programs have been used by partner hospitals for clinical research and treatment.
We have gotten the promising results from the clinical trails with our lead autologous adult stem cell and neural stem cell therapy programs for different kinds of CNS disorders such as parkinson's disease, post stroke, cerebral palsy, ALS (motor neuron disease), MS (multiple sclerosis), brain injury and spinal cord injury (SCI). And more than 100 patients experienced the stem cell therapy with our therapy programs. In addition to our CNS disorder programs, we are developing stem cell approaches for other conditions, including the liver diseases(hepatitis and cirrhosis.), heart failure and peripheral artery diseases.
Cellonis is also advancing the cancer vaccine and cellular therapy for cancer. Our cancer vaccine programs which target at different kinds of solid tumor cells have showed great potential in cancer treatment. Currently Cellonis is exploring the novel cell therapies with the integration of its core stem cell technologies and immune technologies. The patented technologies will allow Cellonis to develop more effective cellular approaches for cancer relapse and metastasis.
Our headquarters and main facilities are located in Beijing. SinoTopCell Limited is a wholly-owned subsidiary of Cellonis located in Hong Kong focus on the international technology development and collaboration